N-(4-Amino-2-pyridyl)-4-(trifluoromethyl)benzamide | 1011244-88-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-Amino-2-pyridyl)-4-(trifluoromethyl)benzamide
• 英文别名: N-(4-aminopyridin-2-yl)-4-(trifluoromethyl)benzamide
• CAS: 1011244-88-4
• 化学式: C₁₃H₁₀F₃N₃O
• 分子量: 281.237
• InChiKey: UZVFMGCLDXIOQW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  68
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-(三氟甲基)苯甲酰胺 在 tris-(dibenzylideneacetone)dipalladium(0) 、 palladium on activated charcoal 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 氢气 、 caesium carbonate 作用下， 以 1,4-二氧六环 、 乙酸乙酯 为溶剂， 反应 3.0h， 生成 N-(4-Amino-2-pyridyl)-4-(trifluoromethyl)benzamide
  参考文献：
  名称：

  EP2070908

  摘要：

  公开号：

文献信息

• COMPOUND HAVING BENZAMIDE SKELETON AND CYCLOOXYGENASE (COX-1)-SELECTIVE INHIBITORY ACTIVITY
  申请人：National University Corporation Okayama University

  公开号：EP2070908A1

  公开（公告）日：2009-06-17

  This invention provides a novel COX-1-selective inhibitor. This invention relates to a novel compound represented by the formula below or a salt thereof. This invention also relates to an analgesic agent, an antiinflammatory agent, an antitumor agent, an antiplatelet aggregation agent, and a cyclooxygenase-1-selective inhibitor comprising, as an active ingredient, such compound or salt thereof.

  本发明提供了一种新型 COX-1 选择性抑制剂。本发明涉及下式所代表的新型化合物或其盐。本发明还涉及一种镇痛剂、一种抗炎剂、一种抗肿瘤剂、一种抗血小板聚集剂和一种环氧化酶-1 选择性抑制剂，其有效成分包括这种化合物或其盐。
• Cyclooxygenase-1-Selective Inhibitors Are Attractive Candidates for Analgesics That Do Not Cause Gastric Damage. Design and in Vitro/in Vivo Evaluation of a Benzamide-Type Cyclooxygenase-1 Selective Inhibitor
  作者：Hiroki Kakuta、Xiaoxia Zheng、Hiroyuki Oda、Shun Harada、Yukio Sugimoto、Kenji Sasaki、Akihiro Tai

  DOI：10.1021/jm701191z

  日期：2008.4.1

  Although cyclooxygenase-1 (COX-1) inhibition is thought to be a major mechanism of gastric damage by nonsteroidal anti-inflammatory drugs (NSAIDs), some COX-1-selective inhibitors exhibit strong analgesic effects without causing gastric damage. However, it is not clear whether their analgesic effects are attributable to COX-1-inhibitory activity or other bioactivities. Here, we report that N-(5-amino-2-pyridinyl)-4(trifluoromethyl)benzamide (18f, TFAP), which has a structure clearly different from those of currently available COX-1-selective inhibitors, is a potent COX-1-selective inhibitor (COX-1IC(50) = 0.80 +/- 0.05 mu M, COX-2IC(50) = 210 I mu M). This compound causes little gastric damage in rats even at an oral dose of 300 mg/kg, though it has an analgesic effect at as low a dose as 10 mg/kg. Our results show that COX-1-selective inhibitors can be analgesic agents without causing gastric damage.
• COMPOUND WITH BENZAMIDE SKELETON HAVING CYCLOOXYGENASE-1 (COX-1)-SELECTIVE INHIBITORY ACTIVITY
  申请人：KAKUTA Hiroki

  公开号：US20100069443A1

  公开（公告）日：2010-03-18

  This invention provides a novel COX-1-selective inhibitor. This invention relates to a novel compound represented by the formula below or a salt thereof. This invention also relates to an analgesic agent, an antiinflammatory agent, an antitumor agent, an antiplatelet aggregation agent, and a cyclooxygenase-1-selective inhibitor comprising, as an active ingredient, such compound or salt thereof.
• EP2070908
  申请人：——

  公开号：——

  公开（公告）日：——